New Fox Chase Attending Physician Focuses on Genitourinary Cancers
PHILADELPHIA (September, 2008) —Betsy Plimack, MD, has joined Fox Chase Cancer Center’s medical oncology staff as an attending physician. She treats patients with genitourinary cancers such as bladder, kidney, prostate and testicular cancers.
Plimack received her MD at New York University and served her internship and residency at NYU Medical Center and Bellevue Hospital.
She also held a fellowship in medical oncology at The University of Texas M. D. Anderson Cancer Center, serving as chief resident. She also earned a master's degree in patient-based biologic research at University of Texas Graduate School of Biomedical Science.
Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute’s prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center’s nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427).